<DOC>
	<DOCNO>NCT02806128</DOCNO>
	<brief_summary>Evaluate effectiveness kallikrein different drug frequency acute anterior circulation cerebral infarction .</brief_summary>
	<brief_title>The Metabolism Research KLK Treating Acute Cerebral Ischemic Stroke : Focus Drug Frequency-Efficacy Relationship</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Kallikreins</mesh_term>
	<criteria>1 . Age 18 80 year old ; 2 . First time diagnosed history acute anterior circulation cerebral infarction without serious sequela ( mRS = 02 ) ; 3 . Acute anterior circulation cerebral infarction large artery atherosclerotic etiology ; 4 . Ability randomize within 48 h time last known free new ischemic symptom . 5 . National Institute Health stroke scale ( NIHSS ) range 7 22 ; 6. sign write informed consent . 1 . Cerebral CT show cerebral hemorrhage disease : cerebral hemorrhage , subarachnoid hemorrhage , etc . ; 2 . Transient ischemic attack ; 3 . Serious disturbance consciousness : Glasgow Coma ScaleGCS（GCS）≤8 ; 4 . Combined angiotensinconverting enzyme inhibitor ( ACEI ) less 5 halftime ( accord instruction ) , need treat ACEI ; 5 . Past present suffer hemorrhagic tendency disease ; 6 . The investigator consideration condition patient n't fit participate clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cerebral infarction</keyword>
	<keyword>kallikrein</keyword>
	<keyword>KLK</keyword>
</DOC>